Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 12/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | CCR2 | P41597 | 1/20 | 0.41 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | PHGDH | O43175 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.32 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piperazine SCHEMBL7550059 | 0.97 | CXCR4 (0.48) | CXCR4SMN1; SMN2MEN1CHRM2CHRM1 | |
| SCHEMBL8200418 | 0.95 | CXCR4 (0.53) | CXCR4SMN1; SMN2MEN1CHRM2CHRM1 | |
| SCHEMBL2772577 | 0.95 | CXCR4 (0.44) | CXCR4SMN1; SMN2MEN1CHRM2CHRM1 | |
| SCHEMBL40173 | 0.95 | — | — | |
| SCHEMBL272114 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL22341586 | 0.92 | CXCR4 (0.43) | CXCR4SMN1; SMN2MEN1CHRM2CHRM1 | |
| Iodide SCHEMBL9066882 | 0.92 | — | — | |
| N-Methyl Pyrrolidine (Nmp) SCHEMBL4901711 | 0.92 | CXCR4 (0.43) | CXCR4SMN1; SMN2MEN1CHRM2CHRM1 | |
| SCHEMBL18828511 | 0.92 | CXCR4 (0.43) | CXCR4SMN1; SMN2MEN1CHRM2CHRM1 | |
| SCHEMBL18851815 | 0.92 | CXCR4 (0.43) | CXCR4SMN1; SMN2MEN1CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180369428-A1 | RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY- ACADEMIC COOPERATION FOUNDATION (KR) | 2018-12-27 | — | — | US | claimed |
| EP-3281643-A2 | RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE | Kyungpook National University Industry-Academic Cooperation Foundation (KR) | 2018-02-14 | — | — | EP | claimed |
| EP-2163553-B1 | ARENE CONNECTED POLYAMINE MACRORING DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF | BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO LTD (CN) | 2013-12-25 | — | — | EP | claimed |
| US-7452845-B2 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-11-18 | — | — | US | claimed |
| EP-1370563-B1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NAT RECH SCIENT (FR) | 2006-09-06 | — | — | EP | claimed |
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2004-06-24 | — | — | US | claimed |
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2026-03-26 | — | — | US | disclosed |
| US-11912650-B2 | Bakuchiol derivatives, pharmaceutically acceptable salts thereof, and preparation method and use of the same | JIANGXI SHIMEI PHARMACEUTICAL CO., LTD (CN) | 2024-02-27 | — | — | US | disclosed |
| US-11912650-B2 | Bakuchiol derivatives, pharmaceutically acceptable salts thereof, and preparation method and use of the same | JIANGXI SHIMEI PHARMACEUTICAL CO., LTD (CN) | 2024-02-27 | — | — | US | disclosed |
| EP-4219437-A1 | BAKUCHIOL DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Jiangxi Shimei Pharmaceutical Co., Ltd. (CN) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023107648-A2 | SYNTHESIS OF ESTER, CARBONATE, AND CARBAMATE-DERIVED NOVEL BIODEGRADABLE IONIZABLE LIPIDS FROM METHYL RICINOLEATE OR METHYL 12-HYDROXYSTEARATE AND ITS APPLICATIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023018990-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2023-02-16 | — | — | WO | disclosed |
| CN-111755746-B | Lithium ion battery electrolyte and lithium ion battery | 比亚迪股份有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-6524372-B1 | Separation and purification of gases; 1,4,8,11-Tetrakis(3-(triethoxysilyl)propyl)-1,4,8,11 -tetraazacyclotetradecane | L′Air Liquide, Societe Anonyme a Directoire et Conseil de Surveillance pour l′Etude et l′Exploitation des Procedes Georges Claude (FR) | 2003-02-25 | — | — | US | disclosed |
| US-6372903-B1 | REACTING POLYAZACYCLOALKANE WITH COMPOUND HAVING FUNCTIONAL SILANE GROUP, CONDENSING PRODUCT WITH SILANOL SITES OF SILICA GEL TO FORM IMMOBILIZED POLYAZACYCLOALKANE | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2002-04-16 | — | — | US | disclosed |
| EP-1051257-B1 | METHOD FOR PREPARING POLYAZACYCLOALKANES GRAFTED ON SILICA GEL AND USE OF GRAFTED COMPOUNDS | AIR LIQUIDE (FR) | 2002-04-03 | — | — | EP | disclosed |
| EP-1051257-A1 | METHOD FOR PREPARING POLYAZACYCLOALKANES GRAFTED ON SILICA GEL AND USE OF GRAFTED COMPOUNDS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2000-11-15 | — | — | EP | disclosed |
| EP-1051422-A1 | SILICA GEL INCORPORATING POLYAZACYCLOALKANE STRUCTURAL UNITS | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999037656-A1 | SILICA GEL INCORPORATING POLYAZACYCLOALKANE STRUCTURAL UNITS | L'AIR LIQUIDE SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 1999-07-29 | — | — | WO | disclosed |
| WO-1999037399-A1 | METHOD FOR PREPARING POLYAZACYCLOALKANES GRAFTED ON SILICA GEL AND USE OF GRAFTED COMPOUNDS | L'AIR LIQUIDE SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 1999-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | KLK3, FOLH1, PSMA1 | CXCR4 1897/4885SMN1; SMN2 3130/4885MEN1 2375/4885 |
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | SCO2, IPO9, IPO4 | CXCR4 1677/4885SMN1; SMN2 2963/4885MEN1 1178/4885 |
| US-20180369428-A1 | RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE | TST, CTH, CBS | CXCR4 3011/4885SMN1; SMN2 1369/4885MEN1 2258/4885 |
| US-11912650-B2 | Bakuchiol derivatives, pharmaceutically acceptable salts thereof, and preparation method and use of the same | CEL, NPC1L1, LIPA | CXCR4 4438/4885SMN1; SMN2 4022/4885MEN1 1191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.